Egfl7 promotes tumor escape from immunity

OncoImmunology

Volumn 1, Issue 3, 2012, Pages 375-376

  Pinte, Sébastien ^a   Soncin, Fabrice ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

Author keywords

Adhesion molecules; Angiogenesis; Endothelium; Escape from immunity; Extravasation

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN EGFL7; REPRESSOR PROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL INFILTRATION; COLON CANCER; DENDRITIC CELL; ENDOTHELIUM CELL; GLIOMA; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG METASTASIS; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR ESCAPE; TUMOR IMMUNITY;

EID: 84886945626     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.18964     Document Type: Article

References (9)

1. Wu NZ, Klitzman B, Dodge R, Dewhirst MW. Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res 1992; 52:4265-8
2. Kuzu I, Bicknell R, Fletcher CD, Gatter KC. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest 1993; 69:322-8
3. Dirkx AE, Oude Egbrink MC, Kujipers MJ, van der Neit ST, Heijnen VV, Bouta-ter Steege JC, et al. Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res 2003; 63:2322-9
4. Delfortrie S, Pinte S, Mattot V, Samson C, Caetano B, Lauridant-Philipphin G, et al. Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation. Cancer Res 2011; 71:7176-86. http://dx.doi.org/10.1158/0008-5472.CAN-11-1301
5. Soncin F, Mattot V, Lionneton F, Spruyt N, Lepretre F, Begue A, et al. VE-statin, an endothelial repressor of smooth muscle cell migration. EMBO J 2003; 22: 5700-11. http://dx.doi.org/10.1093/ emboj/cdg549
6. Lelièvre E, Hinek A, Lupu F, Buquet C, Soncin F, Mattot V. VE-statin/egfl7 regulates vascular elastogenesis by interacting with lysyl oxidases. EMBO J 2008; 27:1658-70. http://dx.doi. org/10.1038/emboj.2008.103
7. Wu F, Yang LY, Li YF, Ou DP, Chen DP, Fan C. Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Hepatology 2009; 50:1839-50. http://dx.doi.org/10.1002/hep.23197
8. Huang CH, Li XJ, Zhou YZ, Luo Y, Li C, Yan XR. Expression and clinical significance of EGFL7 in malignant glioma. J Cancer Res Clin Oncol 2010; 136:1737-43. http://dx.doi.org/10. 1007/s00432-010-0832-9
9. Díaz R, Silva J, Garcia JM, Lorenzo Y, Garcia V, Peña C, et al. Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer 2008; 47:794-802. http://dx.doi.org/10.1002/gcc.20580